Iterum Therapeutics Receives US FDA Approval of ORLYNVAH™ for the Treatment of Uncomplicated Urinary Tract Infections
October 29, 2024
0
Iterum Therapeutics US FDA Approval On October 25, 2024, Iterum Therapeutics (ITRM) announced that the U.S. …